Bio Spectrum - February 2020Add to Favorites

Get Bio Spectrum along with 5,000+ other magazines & newspapers

Try FREE for 7 days

bookLatest and past issues of 5,000+ magazines & newspapersphoneDigital Access. Cancel Anytime.familyShare with 4 family members.

1 Year$99.99

bookLatest and past issues of 5,000+ magazines & newspapersphoneDigital Access. Cancel Anytime.familyShare with 4 family members.
(Or)

Get Bio Spectrum

1 Year $10.99

Save 7%
book12 issues starting from June 2021 phoneDigital Access. Cancel Anytime.

Buy this issue $0.99

bookFebruary 2020 issue phoneDigital Access.

Gift Bio Spectrum

  • Magazine Details
  • In this issue

Magazine Description

In this issue

Indian pharma under USFDA lens India holds a major stake in the US market. Hence US Food Drug Administration (FDA) has imposed stringent regulations to meet the international regulatory requirement which further boosts number of inspections carried out at various facilities on Indian pharmaceutical companies. With the booming generics business, USFDA is keeping a stern watch over the Indian pharma companies to safeguard the health interest of its population. The government of India has been adopting to stringent mechanisms to ensure the quality of drugs into the market. The Ministry of Health has been imposing a mandatory BA/BE studies for all the pharmaceutical manufacturing permissions. Government’s “Make in India” initiative is expected to deliver more safe, efficient and quality drugs into the market. With these and many more initiatives India will continue to be the powerhouse of pharmaceutical industry in coming years.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only
RECENT STORIES FROM BIO SPECTRUMView All